Larry A. Chinitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Larry A. Chinitz has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Aizer
Leon H. Charney Division of Cardiology, NYU Langone Health New York University Grossman School of Medicine New York New York USA
1 shared publication Brian C. Wong
Methodist Medical Center, Brooklyn, New York
1 shared publicationDavid A. Sandler
Heart Rhythm Center, New York University Medical Center, New York, New York, USA
1 shared publicationDavid Y. Feigenblum
Heart Rhythm Center, New York University Medical Center, New York, New York
1 shared publication- Douglas Holmes
New York University, New York, New York, USA
1 shared publication Douglas S. Holmes
Heart Rhythm Center, New York University Medical Center, New York, New York
1 shared publication
Latest Publications
- 1 April 2012
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (6) , 659-664
Right‐Sided Implantation and Subpectoral Position are Predisposing Factors for Fracture of a 6.6 French ICD Lead
Background: The Medtronic Sprint Fidelis (Medtronic Inc., Minneapolis, MN, USA) lead family is associated with an unacceptable incidence of premature lead failure. There are limited data on risk factors for lead fracture. We hypothesized that factors leading to potential increased forces on the lead related to device implantation or technique may be associated with premature lead failure. Methods: We reviewed the implant data from our group and identified 176 patients who received active fixation Medtronic Fidelis (Model 6931, single coil and Model 6949, dual coil) leads. Implant data, including age, sex, venous access site, implant side, implant location, and number of venous leads were reviewed. Hospital, pacemaker clinic, and Medtronic registration databases were reviewed for evidence of lead failure, replacement, or abandonment. Data was evaluated in univariate and multivariate regression analyses. Results: Of the 176 leads implanted, 10 (5.7%) were noted to develop malfunction. This presented as inappropriate shocks from sensed noise or elevated impedance measurements. Of the above noted implant features, only right‐sided (vs left‐sided) implant (hazard ratio [HR] 18.8, 95% confidence intervals [CI] 3.8, 93.3), and subpectoral implant (vs prepectoral; HR 14.31, 95% CI 3.2, 64.0) were predictive of lead failure in maximally adjusted models. Conclusions: We have identified both right‐sided implantation and subpectoral generator positioning as factors associated with premature lead malfunction in Fidelis active fixation leads. Clinical decisions regarding patient management should incorporate these findings in regard to lead replacement in high‐risk patients. (PACE 2012; 35:659–664)
- 1 April 2012
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (6) , 659-664
Right‐Sided Implantation and Subpectoral Position are Predisposing Factors for Fracture of a 6.6 French ICD Lead
Background: The Medtronic Sprint Fidelis (Medtronic Inc., Minneapolis, MN, USA) lead family is associated with an unacceptable incidence of premature lead failure. There are limited data on risk factors for lead fracture. We hypothesized that factors leading to potential increased forces on the lead related to device implantation or technique may be associated with premature lead failure. Methods: We reviewed the implant data from our group and identified 176 patients who received active fixation Medtronic Fidelis (Model 6931, single coil and Model 6949, dual coil) leads. Implant data, including age, sex, venous access site, implant side, implant location, and number of venous leads were reviewed. Hospital, pacemaker clinic, and Medtronic registration databases were reviewed for evidence of lead failure, replacement, or abandonment. Data was evaluated in univariate and multivariate regression analyses. Results: Of the 176 leads implanted, 10 (5.7%) were noted to develop malfunction. This presented as inappropriate shocks from sensed noise or elevated impedance measurements. Of the above noted implant features, only right‐sided (vs left‐sided) implant (hazard ratio [HR] 18.8, 95% confidence intervals [CI] 3.8, 93.3), and subpectoral implant (vs prepectoral; HR 14.31, 95% CI 3.2, 64.0) were predictive of lead failure in maximally adjusted models. Conclusions: We have identified both right‐sided implantation and subpectoral generator positioning as factors associated with premature lead malfunction in Fidelis active fixation leads. Clinical decisions regarding patient management should incorporate these findings in regard to lead replacement in high‐risk patients. (PACE 2012; 35:659–664)
- 29 November 2010
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 22 (6) , 684-690
Contact Sensing Provides a Highly Accurate Means to Titrate Radiofrequency Ablation Lesion Depth
- 29 November 2010
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 22 (6) , 684-690
Contact Sensing Provides a Highly Accurate Means to Titrate Radiofrequency Ablation Lesion Depth
- 1 December 2002
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 25 (12) , 1788-1789
Cardiac Vein Angioplasty for Biventricular Pacing
SANDLER, D.A., et al.; Cardiac Vein Angioplasty for Biventricular Pacing. Biventricular pacing for the treatment of congestive heart failure has consistently demonstrated improvement in quality‐of‐life and reduction in heart failure symptoms. Though the over‐the‐wire systems will be helpful in overcoming many existing obstacles to optimal lead placement, anatomic variability will still limit overall success. Cardiac vein angioplasty may be required for deployment of leads into tortuous or obstructed cardiac veins. This case report describes the angioplasty of a focal cardiac vein stenosis allowing for successful implantation of a left ventricular pacing lead. The safety of this procedure is unknown, though the risks may be acceptable in certain patients.
- 1 December 2002
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 25 (12) , 1788-1789
Cardiac Vein Angioplasty for Biventricular Pacing
SANDLER, D.A., et al.; Cardiac Vein Angioplasty for Biventricular Pacing. Biventricular pacing for the treatment of congestive heart failure has consistently demonstrated improvement in quality‐of‐life and reduction in heart failure symptoms. Though the over‐the‐wire systems will be helpful in overcoming many existing obstacles to optimal lead placement, anatomic variability will still limit overall success. Cardiac vein angioplasty may be required for deployment of leads into tortuous or obstructed cardiac veins. This case report describes the angioplasty of a focal cardiac vein stenosis allowing for successful implantation of a left ventricular pacing lead. The safety of this procedure is unknown, though the risks may be acceptable in certain patients.